Austen Allred portfolio

Austen Allred has 3 portfolio companies on record at Recent Funding.

Type: Angel investor.

Portfolio on Recent Funding: 3.

Deals, last 12 months: 0.

Latest deal: Nucleus Genomics · Jul 14, 2022.

About this page

It is an angel investor. Its most recent investment on record is Nucleus Genomics's Seed round in July 2022, alongside Anthony Pompliano, Packy McCormick, Hugo Barra and 6 others. By category, its portfolio leans toward Health and bio (1) and Commerce and retail (1).

What Austen Allred invests in

Health and bio · 1 · 33%
Commerce and retail · 1 · 33%
AI coding and devtools · 1 · 33%
AI agents · 1 · 33%
Developer tools and cloud · 1 · 33%

How Austen Allred invests

Stage	Deals	Capital in rounds
Seed	1 100%	undisclosed

Austen Allred portfolio companies

NNucleus GenomicsSeed · Jul 2022
TTajirbacker
QQA Wolfbacker

Company	Round with Austen Allred	Total raised	Latest raise
NNucleus Genomics Health and bio	Jul 14, 2022 Seed	undisclosed	Nov 29, 2025 Series A
TTajir Commerce and retail	backer	undisclosed	—
QQA Wolf AI coding and devtools	backer	$36M	Dec 29, 2025 Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Austen Allred. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Austen Allred, which is a subset of its real portfolio. API: /api/v1/investors/austen-allred (get a free API key). More: the most active VC firms and new venture capital funds.